Different NK Cell Surface Phenotypes Defined by the DX9 Antibody Are Due to KIR3DL1 Gene Polymorphism

Different NK Cell Surface Phenotypes

Variable NK cell receptors exemplified by human KIR3DL1/S1.

Variegated expression of variable NK cell receptors for polymorphic MHC class I broadens the range of an individual's NK cell response and the capacity for populations and species to survive disease epidemics and population bottlenecks. On evolutionary time scales, this component of immunity is exceptionally dynamic, unstable, and short-lived, being dependent on coevolution of ligands and recep...

The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1.

KIR3DL1 is an inhibitory HLA-B receptor of human NK and T cells that exhibits genetic and phenotypic polymorphism. KIR3DL1*004, a common allotype, cannot be detected on the surface of PBLs using the KIR3DL1-specific Ab DX9. The nature of this phenotype was investigated through comparison of 3DL1*004 with 3DL1*002, an allele giving high DX9 binding to cell surfaces. Analysis of Jurkat T cell tra...

Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.

NK cells express both inhibitory and activatory receptors that allow them to recognize target cells through HLA class I Ag expression. KIR3DL1 is a receptor that recognizes the HLA-Bw4 public epitope of HLA-B alleles. We demonstrate that polymorphism within the KIR3DL1 receptor has functional consequences in terms of NK cell recognition of target. Inhibitory alleles of KIR3DL1 differ in their a...

T200 cell surface glycoprotein of the mouse. Polymorphism defined by the Ly-5 system of alloantigens

The cell line BW5147, and a mutant T200-negative cell line derived from BW5147, were studed by immunoprecipitation and peptide mapping, with xenogeneic monoclonal anti-T200 serum and with Ly-5 alloantiserum. It appears that the Ly-5 system defines a structural polymorphism of the cell surface glycoprotein T200, and that the monoclonal anti-T200 serum defines a feature of T200 that is common to ...